Myocardial fibrosis in Eisenmenger syndrome: A descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival

Craig Broberg, Sanjay K. Prasad, Chad Carr, Sonya V. Babu-Narayan, Konstantinos Dimopoulos, Michael A. Gatzoulis

    Research output: Contribution to journalArticle

    17 Citations (Scopus)

    Abstract

    Background: A relationship between myocardial fibrosis and ventricular dysfunction has been demonstrated using late gadolinium enhancement (LGE) in the pressure-loaded right ventricle from congenital heart defects. In patients with Eisenmenger syndrome (ES), the presence of LGE has not been investigated. The aims of this study were to detect any myocardial fibrosis in ES and describe major clinical variables associated with the finding. Methods. From 45 subjects screened, 30 subjects (age 43 ± 13 years, 20 female) underwent prospective cardiovascular magnetic resonance with LGE to quantify biventricular volume and function as well as maximal and submaximal exercise during a single visit. Standard cine acquisitions were obtained for ventricular volume and function. Further imaging was performed after administration of 0.1 mmol/kg gadolinium contrast. Regions of LGE were evaluated qualitatively and quantitatively by manual contouring of identified areas, with total area expressed as a percentage of mass. Patients were followed prospectively (mean follow up 7.4 ± 0.4 years) and any deaths recorded. Patients with LGE findings were compared to those without. Results: LGE was present in 22/30 (73%) patients, specifically in RV myocardium (70%), RV trabeculae (60%), LV myocardium (33%) or LV papillary muscles (30%), though in small amounts (mean 1.4% of total ventricular mass, range 0.16 - 6.0%). Those with any LGE were not different in age, history of arrhythmia, desaturation, nor hemoglobin, nor ventricular size, mass, or function. Exercise capacity was low, but also not different between those with and without LGE. Similarly no significant associations were found with amount of fibrosis. There were five deaths among patients with LGE, versus two in patients without, but no difference in survival (log rank =0.03, P = 0.85). Conclusions: Myocardial fibrosis by LGE is common in ES, though not extensive. The presence and quantity of LGE did not correlate with ventricular size, function, degree of cyanosis, exercise capacity, or survival in this pilot study. More data are clearly required before recommendations for routine use of LGE in these patients can be made.

    Original languageEnglish (US)
    Article number32
    JournalJournal of Cardiovascular Magnetic Resonance
    Volume16
    Issue number1
    DOIs
    StatePublished - May 14 2014

    Fingerprint

    Eisenmenger Complex
    Gadolinium
    Fibrosis
    Cohort Studies
    Survival
    Ventricular Function
    Exercise
    Myocardium
    Ventricular Dysfunction
    Cyanosis
    Papillary Muscles
    Congenital Heart Defects

    Keywords

    • Cardiovascular magnetic resonance
    • Cyanosis
    • Eisenmenger
    • Myocardial fibrosis
    • Pulmonary artery hypertension

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine
    • Radiology Nuclear Medicine and imaging
    • Radiological and Ultrasound Technology
    • Family Practice

    Cite this

    Myocardial fibrosis in Eisenmenger syndrome : A descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival. / Broberg, Craig; Prasad, Sanjay K.; Carr, Chad; Babu-Narayan, Sonya V.; Dimopoulos, Konstantinos; Gatzoulis, Michael A.

    In: Journal of Cardiovascular Magnetic Resonance, Vol. 16, No. 1, 32, 14.05.2014.

    Research output: Contribution to journalArticle

    @article{53a616edbcb7492f838f43db12b74da1,
    title = "Myocardial fibrosis in Eisenmenger syndrome: A descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival",
    abstract = "Background: A relationship between myocardial fibrosis and ventricular dysfunction has been demonstrated using late gadolinium enhancement (LGE) in the pressure-loaded right ventricle from congenital heart defects. In patients with Eisenmenger syndrome (ES), the presence of LGE has not been investigated. The aims of this study were to detect any myocardial fibrosis in ES and describe major clinical variables associated with the finding. Methods. From 45 subjects screened, 30 subjects (age 43 ± 13 years, 20 female) underwent prospective cardiovascular magnetic resonance with LGE to quantify biventricular volume and function as well as maximal and submaximal exercise during a single visit. Standard cine acquisitions were obtained for ventricular volume and function. Further imaging was performed after administration of 0.1 mmol/kg gadolinium contrast. Regions of LGE were evaluated qualitatively and quantitatively by manual contouring of identified areas, with total area expressed as a percentage of mass. Patients were followed prospectively (mean follow up 7.4 ± 0.4 years) and any deaths recorded. Patients with LGE findings were compared to those without. Results: LGE was present in 22/30 (73{\%}) patients, specifically in RV myocardium (70{\%}), RV trabeculae (60{\%}), LV myocardium (33{\%}) or LV papillary muscles (30{\%}), though in small amounts (mean 1.4{\%} of total ventricular mass, range 0.16 - 6.0{\%}). Those with any LGE were not different in age, history of arrhythmia, desaturation, nor hemoglobin, nor ventricular size, mass, or function. Exercise capacity was low, but also not different between those with and without LGE. Similarly no significant associations were found with amount of fibrosis. There were five deaths among patients with LGE, versus two in patients without, but no difference in survival (log rank =0.03, P = 0.85). Conclusions: Myocardial fibrosis by LGE is common in ES, though not extensive. The presence and quantity of LGE did not correlate with ventricular size, function, degree of cyanosis, exercise capacity, or survival in this pilot study. More data are clearly required before recommendations for routine use of LGE in these patients can be made.",
    keywords = "Cardiovascular magnetic resonance, Cyanosis, Eisenmenger, Myocardial fibrosis, Pulmonary artery hypertension",
    author = "Craig Broberg and Prasad, {Sanjay K.} and Chad Carr and Babu-Narayan, {Sonya V.} and Konstantinos Dimopoulos and Gatzoulis, {Michael A.}",
    year = "2014",
    month = "5",
    day = "14",
    doi = "10.1186/1532-429X-16-32",
    language = "English (US)",
    volume = "16",
    journal = "Journal of Cardiovascular Magnetic Resonance",
    issn = "1097-6647",
    publisher = "BioMed Central",
    number = "1",

    }

    TY - JOUR

    T1 - Myocardial fibrosis in Eisenmenger syndrome

    T2 - A descriptive cohort study exploring associations of late gadolinium enhancement with clinical status and survival

    AU - Broberg, Craig

    AU - Prasad, Sanjay K.

    AU - Carr, Chad

    AU - Babu-Narayan, Sonya V.

    AU - Dimopoulos, Konstantinos

    AU - Gatzoulis, Michael A.

    PY - 2014/5/14

    Y1 - 2014/5/14

    N2 - Background: A relationship between myocardial fibrosis and ventricular dysfunction has been demonstrated using late gadolinium enhancement (LGE) in the pressure-loaded right ventricle from congenital heart defects. In patients with Eisenmenger syndrome (ES), the presence of LGE has not been investigated. The aims of this study were to detect any myocardial fibrosis in ES and describe major clinical variables associated with the finding. Methods. From 45 subjects screened, 30 subjects (age 43 ± 13 years, 20 female) underwent prospective cardiovascular magnetic resonance with LGE to quantify biventricular volume and function as well as maximal and submaximal exercise during a single visit. Standard cine acquisitions were obtained for ventricular volume and function. Further imaging was performed after administration of 0.1 mmol/kg gadolinium contrast. Regions of LGE were evaluated qualitatively and quantitatively by manual contouring of identified areas, with total area expressed as a percentage of mass. Patients were followed prospectively (mean follow up 7.4 ± 0.4 years) and any deaths recorded. Patients with LGE findings were compared to those without. Results: LGE was present in 22/30 (73%) patients, specifically in RV myocardium (70%), RV trabeculae (60%), LV myocardium (33%) or LV papillary muscles (30%), though in small amounts (mean 1.4% of total ventricular mass, range 0.16 - 6.0%). Those with any LGE were not different in age, history of arrhythmia, desaturation, nor hemoglobin, nor ventricular size, mass, or function. Exercise capacity was low, but also not different between those with and without LGE. Similarly no significant associations were found with amount of fibrosis. There were five deaths among patients with LGE, versus two in patients without, but no difference in survival (log rank =0.03, P = 0.85). Conclusions: Myocardial fibrosis by LGE is common in ES, though not extensive. The presence and quantity of LGE did not correlate with ventricular size, function, degree of cyanosis, exercise capacity, or survival in this pilot study. More data are clearly required before recommendations for routine use of LGE in these patients can be made.

    AB - Background: A relationship between myocardial fibrosis and ventricular dysfunction has been demonstrated using late gadolinium enhancement (LGE) in the pressure-loaded right ventricle from congenital heart defects. In patients with Eisenmenger syndrome (ES), the presence of LGE has not been investigated. The aims of this study were to detect any myocardial fibrosis in ES and describe major clinical variables associated with the finding. Methods. From 45 subjects screened, 30 subjects (age 43 ± 13 years, 20 female) underwent prospective cardiovascular magnetic resonance with LGE to quantify biventricular volume and function as well as maximal and submaximal exercise during a single visit. Standard cine acquisitions were obtained for ventricular volume and function. Further imaging was performed after administration of 0.1 mmol/kg gadolinium contrast. Regions of LGE were evaluated qualitatively and quantitatively by manual contouring of identified areas, with total area expressed as a percentage of mass. Patients were followed prospectively (mean follow up 7.4 ± 0.4 years) and any deaths recorded. Patients with LGE findings were compared to those without. Results: LGE was present in 22/30 (73%) patients, specifically in RV myocardium (70%), RV trabeculae (60%), LV myocardium (33%) or LV papillary muscles (30%), though in small amounts (mean 1.4% of total ventricular mass, range 0.16 - 6.0%). Those with any LGE were not different in age, history of arrhythmia, desaturation, nor hemoglobin, nor ventricular size, mass, or function. Exercise capacity was low, but also not different between those with and without LGE. Similarly no significant associations were found with amount of fibrosis. There were five deaths among patients with LGE, versus two in patients without, but no difference in survival (log rank =0.03, P = 0.85). Conclusions: Myocardial fibrosis by LGE is common in ES, though not extensive. The presence and quantity of LGE did not correlate with ventricular size, function, degree of cyanosis, exercise capacity, or survival in this pilot study. More data are clearly required before recommendations for routine use of LGE in these patients can be made.

    KW - Cardiovascular magnetic resonance

    KW - Cyanosis

    KW - Eisenmenger

    KW - Myocardial fibrosis

    KW - Pulmonary artery hypertension

    UR - http://www.scopus.com/inward/record.url?scp=84902553446&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=84902553446&partnerID=8YFLogxK

    U2 - 10.1186/1532-429X-16-32

    DO - 10.1186/1532-429X-16-32

    M3 - Article

    C2 - 24886403

    AN - SCOPUS:84902553446

    VL - 16

    JO - Journal of Cardiovascular Magnetic Resonance

    JF - Journal of Cardiovascular Magnetic Resonance

    SN - 1097-6647

    IS - 1

    M1 - 32

    ER -